[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts

INTRODUCTION: APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) is a tracer used to ass...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Munk Jensen, Mette, Erichsen, Kamille Dumong, Johnbeck, Camilla Bardram, Björkling, Fredrik, Madsen, Jacob, Bzorek, Michael, Jensen, Peter Buhl, Højgaard, Liselotte, Sehested, Maxwell, Kjær, Andreas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537726/
https://ncbi.nlm.nih.gov/pubmed/23308217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0053410
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak